Press Releases :: VolitionRx Ltd (VNRX)

Mar 3, 2020 8:30 am EST

VolitionRx Limited to Present at Conferences in March 2020

Feb 20, 2020 4:10 pm EST

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

Feb 18, 2020 4:10 pm EST

VolitionRx Limited Schedules Full Year 2019 Earnings Conference Call and Business Update

Feb 18, 2020 8:30 am EST

Volition Unveils Its Epigenetic Toolbox

Feb 7, 2020 5:30 pm EST

VolitionRx Announces Filing of Registration Statements

Jan 13, 2020 9:00 am EST

Volition Develops a New Improved Nu.Q™ Assay Format

Jan 10, 2020 8:00 am EST

VolitionRx Completes Acquisition of Octamer GmbH

Dec 16, 2019 8:30 am EST

VolitionRx Limited Announces Strategic Acquisition

Dec 5, 2019 8:30 am EST

VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test

Dec 3, 2019 8:30 am EST

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

rss_feed News RSS